Evidence map›Paper›PMID 24631510›Full record

ArticleJACC. Cardiovascular imaging2014

Prediction of high-risk plaque development and plaque progression with the carotid atherosclerosis score.

Dongxiang Xu, Daniel S Hippe, Hunter R Underhill, Minako Oikawa-Wakayama, Li Dong, Kiyofumi Yamada, Chun Yuan, Thomas S Hatsukami

Abstract read
In one paragraph

Article in JACC. Cardiovascular imaging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Imaging Approaches to the Diagnosis of Vascular Diseases.Current atherosclerosis reports · 2022
    Review
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Review
  18. Article
  19. MR imaging of vulnerable carotid plaque.Cardiovascular diagnosis and therapy · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dongxiang XuDepartment of Radiology, University of Washington, Seattle, Washington.
Daniel S HippeDepartment of Radiology, University of Washington, Seattle, Washington.
Hunter R UnderhillDepartments of Neurological Surgery and Medicine, University of Washington, Seattle, Washington.
Minako Oikawa-WakayamaDepartment of Radiology, Tohoku University, Sendai, Japan.
Li DongDepartment of Radiology, Anzhen Hospital, Beijing, China.
Kiyofumi YamadaDepartment of Radiology, University of Washington, Seattle, Washington.
Chun YuanDepartment of Radiology, University of Washington, Seattle, Washington.
Thomas S HatsukamiDepartment of Surgery, University of Washington, Seattle, Washington. Electronic address: tomhat@u.washington.edu.

Funding

CARDIOVASCULAR RESEARCH TRAINING PROGRAMT32HL007828 · NHLBI · UNIVERSITY OF WASHINGTON · PI Francis Kim, Farid Moussavi-Harami · 1997 to 2026
$10.2M
Prediction and Progression of Carotid Artery DiseaseR01HL067406 · NHLBI · UNIVERSITY OF WASHINGTON · PI JARVIK, GAIL PAIRITZ · 2002 to 2009
$5.1M
Magnetic Resonance Imaging of Vulnerable PlaqueR01HL073401 · NHLBI · UNIVERSITY OF WASHINGTON · PI HATSUKAMI, THOMAS · 2003 to 2006
$2.3M
MRI IDENTIFICATION OF FIBROUS CAP ATROPHY AND RUPTURER01HL061851 · NHLBI · UNIVERSITY OF WASHINGTON · PI HATSUKAMI, THOMAS · 1998 to 2001
$585k
NHLBI NIH HHS R01 HL061851NHLBI NIH HHS R01HL061851NHLBI NIH HHS R01 HL067406NHLBI NIH HHS R01 HL073401NHLBI NIH HHS R01HL073401NHLBI NIH HHS R01HL67406NHLBI NIH HHS T32 HL007828NHLBI NIH HHS T32HL7838
6 · The paper itself

Abstract

objectivesThe goal of this prospective study was to evaluate the carotid atherosclerosis score (CAS) for predicting the development of high-risk plaque features and plaque burden progression.

backgroundPrevious studies have shown that carotid intraplaque hemorrhage (IPH) and a disrupted luminal surface (DLS), as identified by using magnetic resonance imaging, are associated with greater risk for cerebrovascular events. On the basis of data from a large cross-sectional study, a scoring system was developed to determine which plaque features are associated with the presence of IPH and DLS. However, the predictive value of CAS has not been previously tested in a prospective, longitudinal study.

methodsA total of 120 asymptomatic subjects with 50% to 79% carotid stenosis underwent carotid magnetic resonance imaging scans at baseline and 3 years thereafter. Presence of IPH and DLS, wall volume, maximum wall thickness, and maximum percent lipid-rich necrotic core area were measured at both time-points. Baseline CAS values were calculated on the basis of previously published criteria.

resultsOf the 73 subjects without IPH or DLS at baseline, 9 (12%) developed 1 or both of these features during follow-up. There was a significant increasing trend between CAS and the development of new DLS (p < 0.001) and with plaque burden progression (p = 0.03) but not with the development of new IPH (p = 0.3). Percent carotid stenosis was not significantly associated with new DLS (p = 0.2), new IPH (p = 0.1), or plaque progression (p = 0.6).

conclusionsCAS was found to have a significant increasing relationship with incident DLS and plaque progression in this prospective study. CAS can potentially provide improved risk stratification beyond luminal stenosis.

Indexed as

Magnetic Resonance AngiographyPlaque, AtheroscleroticAgedAged, 80 and overAsymptomatic DiseasesCarotid ArteriesCarotid StenosisDisease ProgressionFemaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedNecrosisPredictive Value of Testscarotid atherosclerosis scoredisrupted luminal surfaceplaque progressionstenosis

Identifiers

PMID24631510
PMCPMC4046843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.